Gene Therapy Market

Gene Therapy Market Size, Share & Trends Analysis Report By Vector Type (Viral, Non-viral), By Delivery Method (In Vivo, Ex Vivo), By Gene Type (Cytokine, Antigen, Suicide, Tumor Suppressor, Receptors, Deficiency, Others), By Application (Rare Diseases, Oncological Disorders, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases, Others), Based On Region, And Segment Forecasts, 2022 – 2029


Report
  • Product Id: BMRC 417
  • Pages: 300
  • Publish Date: Jun-2023
  • Category: Healthcare
VishalSawant
Vishal Sawant
Business Development
vishal@brandessenceresearch.com
+91 8830 254 358
AjayRana
Ajay Rana
Business Development
ajay@brandessenceresearch.com
+91 7447 409 162
GDPR
1
Fill Details
2
Verify Email
3
Check your inbox for Sample + Methodology

Note: For delivery of sample pages you must have a Domain Specific EmailID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc are not accepted


Segmentation
Segments

By Type of Therapy

  • Germline Gene Therapy
  • Somatic Gene Therapy

By Vector Type

  • Viral Vectors
  • Non-Viral Vectors

By Technology

  • CRISPR-Cas9
  • Zinc Finger Nucleases
  • TALENs
  • Antisense Oligonucleotides
  • Other Gene Editing Technologies

By Application

  • Rare Diseases
  • Cancer
  • Neurological Disorders
  • Ophthalmic Diseases
  • Cardiovascular Diseases
  • Immunodeficiency Disorders
  • Others

By End-user

  • Hospitals
  • Research Institutes
  • Biotechnology Companies
  • Pharmaceutical Companies
Country
Regions and Country

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of MEA
Company
Key Players
  • Audentes Therapeutic
  • AveXis, Inc.
  • BioMarin Pharmaceutical Inc.
  • Bluebird Bio, Inc.
  • Gilead Sciences, Inc.
  • Homology Medicines, Inc.
  • Krystal Biotech, Inc.
  • Novartis AG
  • Orchard Therapeutics PLC
  • Pfizer Inc.
  • Regenxbio Inc.
  • Rocket Pharmaceuticals, Inc.
  • Sangamo Therapeutics, Inc.
  • Spark Therapeutics, Inc.
  • UniQure N.V.
  • Others

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

BrandEssence® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®

PaymentModes